NetScientific plc (AIM:NSCI, ‘NetScientific’ or ‘the Company’), the biomedical and healthcare technology investment group, today announces that it has entered into a new service agreement with Peter Thoms, a director of the Company, terminable on six months’ notice by either party. Following this, the Remuneration Committee has today awarded him options to acquire up to 119,673 shares on or after 16 September 2014 and up to a further 119,674 shares on or after 16 September 2015. These options replace the unvested 239,347 options granted to Mr Thoms previously and are exercisable at the IPO placing price of 160p per share but only vesting as and when the Remuneration Committee decides. The Remuneration Committee can decide the extent to which these options can become exercisable earlier for reasons of death, permanent disability or other cessation of employment. The dates 16 September 2014 and 2015 are the first and second anniversaries of the Company’s IPO and have been set so as to correspond to the option exercise dates for the Company’s other executive directors.